IDiyas

For the Inventor, By the Inventor

Bonn, Germany

Jurgen Bajorath

USPTO Granted Patents = 23 

Average Co-Inventor Count = 5.2

ph-index = 13

Forward Citations = 907(Granted Patents)


Location History:

  • Mountlake Terrace, WA (US) (1996)
  • Everett, WA (US) (1996 - 2002)
  • Lynwood, WA (US) (2006 - 2008)
  • Lynnwood, WA (US) (1999 - 2011)
  • Bonn, DE (2007 - 2019)

Company Filing History:

goldMedal20 out of 3,681 
 
Bristol-myers Squibb Compnay
 patents
silverMedal1 out of 2,882 
 
The General Hospital Corporation
 patents
bronzeMedal1 out of 2,961 
 
Harvard College
 patents
4. 1 out of 2 
 
Karo Bio Aktiebolag
 patents
5. 2 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1996-2019

Loading Chart...
23 patents (USPTO):Explore Patents
1. 10370428 - Methods of treatment using CTLA4 mutant molecules (2019-08-06),
2. 9758565 - Methods of treatment using CTLA4 mutant molecules (2017-09-12),
3. 8785398 - Methods of treatment using CTLA4 mutant molecules (2014-07-22),
4. 7915395 - Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell (2011-03-29),
5. 7829534 - Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules (2010-11-09),
6. 7700556 - Methods of treatment using CTLA4 mutant molecules (2010-04-20),
7. 7455835 - Methods for treating immune system diseases using a soluble CTLA4 molecule (2008-11-25),
8. 7439230 - Methods of treatment using CTLA4 mutant molecules (2008-10-21),
9. 7304033 - Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules (2007-12-04),
10. 7105166 - Soluble CTLA4 mutant molecules and uses thereof (2006-09-12),
11. 7094874 - Soluble CTLA4 mutant molecules (2006-08-22),
12. 6482919 - Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell (2002-11-19),
13. 6413514 - Methods of using antibodies against human CD40 (2002-07-02),
14. 6372215 - Monoclonal antibodies to human CD6 (2002-04-16),
15. 6312693 - Antibodies against human CD40 (2001-11-06),

Title: The Innovative Journey of Jurgen Bajorath

Introduction:

Jurgen Bajorath, a distinguished inventor hailing from Bonn, Germany, has made significant contributions to the field of innovation through his groundbreaking work in various scientific domains.

Latest Patents:

Jurgen Bajorath's recent patents showcase his expertise in developing novel methods for drug discovery, particularly in the areas of computational chemistry and bioinformatics. These patents highlight his commitment to advancing the field of pharmaceutical research.

Career Highlights:

With a career spanning over three decades, Jurgen Bajorath has held key positions in leading research institutions and universities, where he has spearheaded numerous research projects. His work has been instrumental in shaping the future of drug discovery and molecular informatics.

Collaborations:

Throughout his career, Jurgen Bajorath has collaborated with renowned scientists, researchers, and industry experts to drive innovation and scientific discovery. His collaborative efforts have resulted in groundbreaking advancements in the field of computational chemistry and pharmaceutical sciences.

Conclusion:

Jurgen Bajorath's unwavering dedication to innovation and his pioneering research in drug discovery have solidified his reputation as a visionary inventor. His contributions continue to inspire the next generation of scientists and researchers to push the boundaries of scientific exploration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…